Form 4: Biote Corp. Director Debra L. Morris Reports Stock Transactions

Director Debra L. Morris reports acquisition and disposal of Biote Corp. Class A Common Stock and Restricted Stock Units (RSUs).

Summary

• On May 13, 2025, Debra L. Morris, a director of Biote Corp., reported transactions involving the company's stock.
• Morris acquired 11,045 shares of Class A Common Stock through the vesting of Deferred Settlement RSUs.
• Following the transaction, Morris directly owns 50,155 shares of Class A Common Stock.
• Morris also acquired 21,407 Deferred Settlement RSUs that will vest in either 2026 or upon separation from service.
• Additionally, Morris acquired a stock option to buy 104,547 shares of Class A Common Stock at an exercise price of $3.91, vesting on May 13, 2026, or the day before the 2026 Annual Meeting of Stockholders.
• The report was filed on May 14, 2025.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, so the sentiment is neutral.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, which is common practice and required by the SEC to ensure transparency and prevent insider trading.

Stakeholder Impact

• The transactions may provide insights to stakeholders regarding management's view of the company's prospects.

Key Dates

Keywords

Form 4, Beneficial Ownership, Debra L. Morris, Biote Corp., BTMD, Director, Class A Common Stock, Restricted Stock Units, RSU, Stock Option, Vesting